Technologies
Mersana Therapeutics Inc (MRSN) Has Great Growth Outlook For 2025
Mersana Therapeutics Inc (NASDAQ:MRSN) has a beta value of 1.30 and has seen 2.47 million shares traded in the last trading session. The company, currently
Mersana Therapeutics Inc (NASDAQ:MRSN) has a beta value of 1.30 and has seen 2.47 million shares traded in the last trading session. The company, currently
© 2024, Powered by Smart TechOne